Chris Bowden

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Agnes Lee, Mark N. Levine, Ross Baker et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism

Agnes Lee, Frederick R. Rickles, Jim A. Julian et al. · Journal of Clinical Oncology · 2005 · 453 citations · Full text

Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma

Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat et al. · Journal of Clinical Oncology · 2020 · 285 citations · Full text

ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Bruce E. Johnson, Fairooz F. Kabbinavar, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML

Sung Choe, Hongfang Wang, Courtney D. DiNardo et al. · Blood Advances · 2020 · 188 citations · Full text